Regeneron Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/30/2026 | 27,414 | 0.1% | 35,516 | 12/31/2025 |
| 2025 Q3 | 11/7/2025 | 20,899 | 0.1% | 37,169 | 9/30/2025 |
| 2025 Q2 | 7/31/2025 | 19,017 | 0.1% | 36,223 | 6/30/2025 |
| 2024 Q4 | 1/31/2025 | 28,363 | 0.1% | 39,817 | 12/31/2024 |
| 2024 Q3 | 11/4/2024 | 41,880 | 0.2% | 39,839 | 9/30/2024 |
| 2024 Q2 | 8/7/2024 | 41,872 | 0.2% | 39,839 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 58,972 | 0.2% | 61,270 | 3/31/2024 |
| 2023 Q4 | 2/2/2024 | 53,813 | 0.2% | 61,270 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 50,551 | 0.2% | 61,426 | 9/30/2023 |
| 2023 Q2 | 8/2/2023 | 45,412 | 0.2% | 63,200 | 6/30/2023 |
| 2023 Q1 | 4/26/2023 | 51,930 | 0.2% | 63,200 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 45,598 | 0.2% | 63,200 | 12/31/2022 |
| 2022 Q3 | 10/28/2022 | 43,737 | 0.2% | 63,491 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 36,874 | 0.1% | 62,379 | 6/30/2022 |
| 2022 Q1 | 5/3/2022 | 43,567 | 0.1% | 62,379 | 3/31/2022 |
| 2021 Q4 | 1/31/2022 | 39,090 | 0.1% | 61,899 | 12/31/2021 |
| 2021 Q3 | 10/27/2021 | 37,682 | 0.1% | 62,266 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 34,856 | 0.1% | 62,406 | 6/30/2021 |
| 2021 Q1 | 4/27/2021 | 29,756 | 0.1% | 62,890 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 30,820 | 0.1% | 63,795 | 12/31/2020 |
| 2020 Q3 | 10/27/2020 | 37,529 | 0.1% | 67,042 | 9/30/2020 |
| 2020 Q2 | 8/4/2020 | 37,465 | 0.2% | 60,074 | 6/30/2020 |
| 2020 Q1 | 6/19/2020 | 29,276 | 0.1% | 59,957 | 3/31/2020 |
| 2019 Q4 | 1/31/2020 | 22,513 | 0.1% | 59,957 | 12/31/2019 |